This company listing is no longer active
IQMD.U Stock Overview
Intelligent Medicine Acquisition Corp. does not have significant operations. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Intelligent Medicine Acquisition Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$10.98 |
52 Week High | US$11.00 |
52 Week Low | US$9.90 |
Beta | 0 |
11 Month Change | 6.91% |
3 Month Change | 6.19% |
1 Year Change | 8.39% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 8.71% |
Recent News & Updates
Recent updates
Shareholder Returns
IQMD.U | US Capital Markets | US Market | |
---|---|---|---|
7D | 4.7% | 2.5% | 1.6% |
1Y | 8.4% | 55.7% | 32.3% |
Return vs Industry: IQMD.U exceeded the US Capital Markets industry which returned -6.9% over the past year.
Return vs Market: IQMD.U exceeded the US Market which returned -5.3% over the past year.
Price Volatility
IQMD.U volatility | |
---|---|
IQMD.U Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 3.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: IQMD.U has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IQMD.U's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | Greg Simon | iqmdspac.com/home/default.aspx |
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
Intelligent Medicine Acquisition Corp. Fundamentals Summary
IQMD.U fundamental statistics | |
---|---|
Market cap | US$64.75m |
Earnings (TTM) | US$11.41m |
Revenue (TTM) | n/a |
5.7x
P/E Ratio0.0x
P/S RatioIs IQMD.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IQMD.U income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | -US$11.41m |
Earnings | US$11.41m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 1.95 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did IQMD.U perform over the long term?
See historical performance and comparison